logo

Athenex, Inc. (ATNX)



Trade ATNX now with
  Date
  Headline
12/27/2017 8:04:22 AM Athenex Receives Promising Innovative Medicine Designation From United Kingdom MHRA For Oraxol
12/15/2017 8:05:39 AM Athenex Initiates Development Of An IND Preparation For Oral Eribulin
12/1/2017 8:06:39 AM Athenex CFO Nick Riehle Retires, Effective December 31
11/9/2017 7:44:31 AM Athenex Q3 Net Loss Attributable To Athenex $23.27 Mln Vs Loss $24.6 Mln Last Year
10/5/2017 8:08:29 AM Athenex Reports Positive Recommendations From DSMB To Continue Oraxol Phase III Program
9/25/2017 8:06:29 AM Athenex Unveils First Patient Recruitment In Phase III Trials For KX-01 Ointment For Actinic Keratosis
9/11/2017 8:09:27 AM ContraVir Pharma Receives HBV IND Approval For Tenofovir Exalidex In The United States
  
 
>